Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBS of Nucleus Accumbens/ALIC for Refractory OCD
NCT02601677Unknown
- Sponsor
- Tangdu Hospital
- Start
- Nov 2015
- Primary completion
- Nov 2018
01
Overview
Randomised trial (2 arms), sponsored by Tangdu Hospital. Primary endpoint: Yale-Brown Obsessive Compulsive Scale at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT02601677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02601677.